Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial - Gillison, M L; Trotti, A M; Harris, J (Lancet, 2019)
et al.